Bedrijfsoverzicht
Garden Stage Limited, operating under the ticker GSIW, functions as a provider of comprehensive financial services primarily within the Hong Kong market. The entity specializes in securities dealing and brokerage, alongside offering underwriting, investment advisory, due diligence, and asset management services to its clientele. This organization operates within the Financial Services sector, specifically categorized under the Capital Markets industry, which implies its role in facilitating capital formation and trading activities. The company maintains a market capitalization of $26.57M and reported annual revenue (TTM) of $8.09M, while the employee count is not disclosed in available records. These valuation and revenue figures suggest that Garden Stage Limited holds a small-cap status, indicating it is a micro-cap entity with limited resources relative to large-scale financial institutions. The significant disparity between its revenue base and its market capitalization further highlights the specific niche or speculative nature often associated with companies in this size bracket within the capital markets sector.
Financiële gezondheid
Garden Stage Limited generated revenue of $8.09M over the trailing twelve months, yet it recorded a net income of $-7,537,693, while EBITDA figures are unavailable. The substantial gap between the positive revenue of $8.09M and the negative net income of $-7,537,693 reveals a highly expansive cost structure where operating expenses significantly exceed total revenues. The company currently holds cash reserves of $10.30M, whereas its total debt stands at $140,745, indicating a strong liquidity position despite the accounting losses. Although specific free cash flow data is not provided, the presence of $10.30M in cash against minimal debt suggests a theoretically flexible balance sheet regarding interest obligations. The company reports a gross margin of 5.3%, an operating margin of -192.2%, and a profit margin of -93.2%, illustrating that costs are far outpacing revenue generation at every level of the income statement. With a debt-to-equity ratio of 0.71, the balance sheet is not highly leveraged, as the company's debt load is less than its equity base. Furthermore, the current ratio of 2.51 indicates that the company possesses ample current assets to cover its short-term liabilities, suggesting robust short-term liquidity. The return on equity stands at -56.3% and return on assets at -31.4%, metrics that reveal management is currently destroying value rather than generating returns for shareholders or utilizing assets efficiently.
Waarderingsbeoordeling
Garden Stage Limited does not have a trailing P/E ratio or a forward P/E ratio available, primarily because the company is reporting net losses which render these traditional earnings-based valuation metrics inapplicable. The absence of a P/E ratio implies that valuation is currently driven by asset value or sales multiples rather than earnings performance. The price-to-book ratio is recorded at 1.03, indicating that the market values the company's equity at roughly 103% of its book value. This slight premium over book value suggests that the market perceives some intangible value or future potential in the company's assets, despite the lack of current earnings. The price-to-sales ratio is 3.29, and the EV/EBITDA ratio is unavailable; these alternative metrics suggest that the company is valued based on its ability to generate revenue rather than profitability. The stock has a 52-week high of $358.00 and a 52-week low of $8.00, meaning the current trading price sits significantly below the 52-week high, reflecting high volatility or a correction from previous peaks. The beta value is 2.48, which indicates that the stock price is highly volatile and is expected to move with more intensity than the broader market, amplifying both potential gains and losses.
Growth & Income
The company reported a revenue growth year-over-year of 414.6%, while earnings growth is not available due to the negative earnings position. The rapid expansion of revenue without corresponding earnings growth implies that the company is likely in a heavy investment or loss-making phase where top-line expansion is prioritized over immediate profitability. As a non-dividend payer, Garden Stage Limited does not distribute cash to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests all of its available cash flow and retained earnings back into its operations or growth initiatives rather than distributing them. The overall growth and income profile is characterized by explosive revenue expansion coupled with significant operational losses and a total absence of dividend income for shareholders. This dynamic creates a high-risk, high-revenue-growth narrative where income generation is deferred entirely to future periods once the company achieves profitability.